Alpha Paradigm Partners, LLC Rocket Pharmaceuticals, Inc. Transaction History
Alpha Paradigm Partners, LLC
- $239 Million
- Q4 2022
A detailed history of Alpha Paradigm Partners, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpha Paradigm Partners, LLC holds 20,165 shares of RCKT stock, worth $235,527. This represents 0.16% of its overall portfolio holdings.
Number of Shares
20,165
Previous 9,404
114.43%
Holding current value
$235,527
Previous $150,000
162.67%
% of portfolio
0.16%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$207 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$131 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$72.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$64.7 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$52.5 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $884M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...